Gutwerg Ori 4
4 · ANI PHARMACEUTICALS INC · Filed Mar 10, 2026
Research Summary
AI-generated summary of this filing
ANI Pharmaceuticals SVP Ori Gutwerg Withholds 3,314 Shares for Taxes
What Happened Ori Gutwerg, SVP, Generics at ANI Pharmaceuticals (ANIP), had 3,314 shares withheld to satisfy tax withholding related to the vesting of restricted stock. The shares were valued at $74.04 each, for a total value of $245,369. This was a tax-withholding disposition (transaction code F), not an open-market sale or purchase.
Key Details
- Transaction date: 2026-03-07; Filing date: 2026-03-10 (appears timely).
- Price per share: $74.04; Shares withheld/disposed: 3,314; Total value: $245,369.
- Shares withheld were to cover taxes on the vesting of 6,476 restricted shares (see footnote).
- Footnote: The withholding is exempt under Rule 16b-3 in connection with the previously reported restricted stock grant.
- Shares owned after the transaction: not specified in the provided filing excerpt.
Context This transaction is a routine tax-withholding event tied to restricted stock vesting (cashless/tax withholding), not a market sale by the insider. Such withholdings satisfy payroll tax obligations and are common following equity vesting; they do not necessarily indicate the insider’s view of the company’s prospects.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-03-07$74.04/sh−3,314$245,369→ 81,468 total
Footnotes (1)
- [F1]Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,476 shares of restricted stock, the grant of which was previously reported.